OTC Pharmaceuticals - Japan

Japan

Revenue in the OTC Pharmaceuticals market in Japan amounted to ¥€7.77bn in 2024.
It is projected to grow annually by 3.53% (CAGR 2024-2029).
The largest market within this market is Other OTC Pharmaceuticals, with a market volume of ¥€2.08bn in 2024.
In comparison to other countries, the in the United States generates the highest revenue, reaching ¥€37,850.00m in 2024.
When considering the total population, per capita revenues in Japan amount to ¥€63.35 in 2024.
Online sales are expected to contribute 23.52% of the total revenue in the OTC Pharmaceuticals market by 2024.
Japan's OTC Pharmaceuticals market is witnessing a surge in demand for traditional herbal remedies, reflecting a strong preference for natural and holistic healthcare solutions.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The OTC Pharmaceuticals market in Japan has been experiencing steady growth in recent years.

Customer preferences: Japanese consumers have shown a growing preference for self-medication and over-the-counter (OTC) medications. This can be attributed to several factors, including the convenience of purchasing medications without a prescription, the increasing availability of OTC products in pharmacies and convenience stores, and the desire for immediate relief from common ailments. Additionally, the aging population in Japan has led to a higher demand for OTC medications, as older individuals often require frequent treatment for chronic conditions.

Trends in the market: One notable trend in the OTC Pharmaceuticals market in Japan is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of their health and are seeking alternative treatments that are perceived as safer and more natural. This trend is reflected in the growing number of OTC products that are derived from natural ingredients, such as herbal extracts and traditional Japanese remedies.Another trend in the market is the rise of online sales of OTC medications. With the increasing popularity of e-commerce in Japan, consumers are now able to conveniently purchase OTC products from online retailers. This has opened up new opportunities for both domestic and international manufacturers to reach a wider customer base.

Local special circumstances: Japan has a unique regulatory environment for OTC medications. The country has a strict approval process for OTC products, which ensures the safety and efficacy of these medications. This regulatory framework has helped build trust among consumers and has contributed to the growth of the OTC Pharmaceuticals market in Japan.Additionally, the Japanese government has implemented various healthcare policies to promote self-medication and reduce the burden on healthcare facilities. These policies include the establishment of a system that allows pharmacists to provide consultations and recommendations for OTC medications. This has further encouraged consumers to seek OTC solutions for their healthcare needs.

Underlying macroeconomic factors: The OTC Pharmaceuticals market in Japan is influenced by several macroeconomic factors. The country's aging population and high life expectancy contribute to the demand for OTC medications, as older individuals often require treatment for chronic conditions. Additionally, the high level of healthcare expenditure in Japan, coupled with the increasing cost of prescription medications, has led many consumers to turn to OTC products as a more affordable alternative.Furthermore, the COVID-19 pandemic has had a significant impact on the OTC Pharmaceuticals market in Japan. The increased focus on health and hygiene has led to a surge in demand for OTC products such as hand sanitizers, vitamins, and immune-boosting supplements. This trend is expected to continue in the foreseeable future, as consumers prioritize preventive healthcare measures.In conclusion, the OTC Pharmaceuticals market in Japan is experiencing steady growth, driven by customer preferences for self-medication, the popularity of natural remedies, the rise of online sales, and the unique regulatory environment. The market is also influenced by macroeconomic factors such as the aging population, healthcare expenditure, and the impact of the COVID-19 pandemic.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.